8-K Filing

Company

Eton Pharmaceuticals, Inc.

Filed

June 15, 2023

Period of Report

June 9, 2023

Accession Number

0001493152-23-021435

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →